Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism

Ilayda Ozsan McMillan, Jin-Ping Li, Lianchun Wang

Open source

DOI
10.1152/ajpcell.00247.2022
Published
2023-04-01
Container
American Journal of Physiology-Cell Physiology
Publisher
American Physiological Society
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1152/ajpcell.00247.2022,
  title = {Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism},
  author = {Ilayda Ozsan McMillan and Jin-Ping Li and Lianchun Wang},
  year = {2023},
  journal = {American Journal of Physiology-Cell Physiology},
  doi = {10.1152/ajpcell.00247.2022},
  url = {https://doi.org/10.1152/ajpcell.00247.2022}
}

RIS

TY  - JOUR
TI  - Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism
AU  - Ilayda Ozsan McMillan
AU  - Jin-Ping Li
AU  - Lianchun Wang
PY  - 2023
JO  - American Journal of Physiology-Cell Physiology
DO  - 10.1152/ajpcell.00247.2022
UR  - https://doi.org/10.1152/ajpcell.00247.2022
ER  - 

APA

McMillan, I. O., Li, J., & Wang, L. (2023). Heparan sulfate proteoglycan in Alzheimer’s disease: aberrant expression and functions in molecular pathways related to amyloid-β metabolism. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00247.2022

Source records